ltrasound as an auxiliary tool in the diagnosis and treatment of patients with Myofascial Pain Syndrome. A randomized clinical trial

Departamento de Anestesiologia da Faculdade de Medicina de Botucatu0 个研究点开始时间: 2017年11月14日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Adult participants 18 years of age or older who voluntarily signed the ICC and who have at least one active or latent Trigger Point located in the cervical, lumbar or shoulder region (trapezius, scapula lift , supraspinatus, infraspinatus), with symptoms for at least 3 months and receiving treatment, without alteration in the dosing schedule, for at least 1 month. These patients may not have undergone other invasive procedures for pain control, such as infiltration with local anesthetics of PGs, in the last 30 days.

•Patients with the following clinical conditions will be excluded from the study:
•active skin lesions, uncontrolled diabetes mellitus, neurodegenerative diseases,
•fibromyalgia, uncontrolled arterial hypertension, known allergy to the local anesthetic
•presence of active bacterial infection, use of anticoagulation with
•altered coagulogram, patient request to leave the study and those who have low cognitive level and who do not understand the evaluation scales used.
•There will be no limitation between genres.

发起方

Departamento de Anestesiologia da Faculdade de Medicina de Botucatu